AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01514942 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Folic acid, vit B12
Description: Folic acid (200 mcg), vit B12 (1.25 mcg) (2 per day)
Study NCT05027815 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells
Description: cryopreserved cellular therapy product in cryostor CS5, for IV infusion
Study NCT04282629 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Milrinone Injection
Description: administration of milrinone (0.75 μg / kg / min, intravenous) from Day 4 to Day 14
Study NCT04282629 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: administration of placebo (intravenous glucose 5%) from Day 4 to Day 14
Study NCT05183347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1291583
Description: BI 1291583
Study NCT05183347 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06529796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IXP
Description: Tablet for oral administration.
Study NCT06542900 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS)
Description: The DBS lead is stereotactically introduced into the target in the brain (SCC, VC/VS, ALIC, ITP, NAc, LHb, MFB, or other unreported nuclei targets) and fixed to the skull; the lead is then connected to a neurostimulator implanted subcutaneously in the subclavicular region.
Study NCT06517095 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: improved capsular polishing
Description: In the polished group,utilize the OVDs to partially fill the peripheral capsule, causing the central posterior capsule to bulge, and then employ the double-ended Whitman Shepherd capsular polisher to meticulously polish both the anterior and equator of the capsule. This process also allows for simultaneous polishing of a portion of the posterior capsule. By rotating the polisher 180°along one side, followed by switching ends to cover the remaining 180° range, even the main incision site can be effectively addressed due to its curved tip design.
Study NCT06517095 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: the conventional I/A polishing
Description: the conventional I/A polishing the capsule
Study NCT06431334 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Amino Acid Intake
Description: Amino acid intakes will vary between 0.5 to 2.8 g/kg/d
Study NCT05801861 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active 10-Hz TMS to the parietal cortex
Description: The active 10-Hz TMS group will receive 10hz TMS stimulation in the first TMS session, and single pulse TMS in the second TMS session. Participants in the active stimulation group will receive 10-Hz TMS to right parietal cortex. The TMS target will be based on subject specific anatomical MRI images (diffusion imaging). TMS will be delivered using a robotic neuronavigation system (Smartmove, ANT). Stimulation intensity will be standardized at 110% of RMT and adjusted to the skull to cortical surface based on e-field calculations (simnibs). Stimulation will be delivered to the right parietal cortex using an active/placebo figure-8 coil, an magventure TMS device.
Study NCT05801861 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active single pulse TMS to the parietal cortex
Description: The active single pulse TMS group will receive single pulse TMS stimulation in the first and second TMS session. Participants in the active stimulation group will receive single pulse TMS to right parietal cortex. The TMS target will be based on subject specific anatomical MRI images (diffusion imaging). TMS will be delivered using a robotic neuronavigation system (Smartmove, ANT). Stimulation intensity will be standardized at 110% of RMT and adjusted to the skull to cortical surface based on e-field calculations (simnibs). Stimulation will be delivered to the right parietal cortex using an active/placebo figure-8 coil, an magventure TMS device.
Study NCT05801861 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham 10-Hz TMS to the right parietal cortex
Description: The parameters in the active arms will be as above with the internal randomization of the device internally switching to sham in a blinded fashion.
Study NCT05801861 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham single-pulse rTMS the rigt parietal cortex
Description: The parameters in the active arms will be as above with the internal randomization of the device internally switching to sham in a blinded fashion.
Study NCT04248946 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: tDCS alters neural excitability in a polarity-specific manner via a weak direct electric current delivered through electrodes placed on the scalp. There are 3 types of stimulation: anodal, cathodal, and sham. In anodal tDCS, the positive electrode is placed over the target brain area to increase neuronal excitability. In cathodal tDCS, the negative electrode is placed over the target brain area to decrease neuronal excitability. Sham tDCS emulates the physical sensations of active (anodal/cathodal) tDCS but current is only delivered for a short period of time and is not enough to cause any neuromodulations
Study NCT06086431 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% sodium chloride
Description: administration of 0.5ml/kg of 0,2% ropivacaine + 0.01ml/kg 0.9% sodium chloride for the erector spine plane block
Study NCT05201326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab，Irinotecan and Re-radiotherapy
Description: All patients with recurrent glioblastoma will accept irinotecan and bevacizumab combined with re-radiotherapy .
Study NCT06086431 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: administration of 0.5ml/kg of 0.2% ropivacaine with 0.1mg/kg Dexamethasone for the erector spine plane block
Study NCT06086431 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: administration of 0.5ml/kg of 0.2% ropivacaine with 0.1ug/kg Dexmedetomidine for the erector spine plane block
Study NCT05613959 — intervention group
Intervention type: DEVICE
Intervention: Veress +
Description: The Veress+ safety mechanism was used
Study NCT05613959 — intervention group
Intervention type: DEVICE
Intervention: Conventional Veress
Description: The Conventional Veress Needle was used
Study NCT06079996 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CAFFEINE GUM
Description: Observing the effect of chewing gum on the performance of female softball players.
Study NCT06079996 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: CAFFEINE GUM
Description: Observing the effect of chewing gum on the performance of female softball players.
Study NCT05313399 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Palatal Crib
Description: An intraoral appliance approach can be used as an adjunct method to stop the habit. Appliances consisting of cribs in the anterior region are very efficient as reminders and physical restrainers. The palatal crib works as an obstacle in non-nutritive sucking and maintains the tongue in a more retruded position, halting its interposition between the incisors.
Study NCT04823650 — intervention group
Intervention type: DEVICE
Intervention: COHORT A: Actigraph
Description: The ActiGraph CentrePoint Insight Watch is a small worn activity monitor designed for documenting physical movement associated with applications in physiological monitoring.
Study NCT04823650 — intervention group
Intervention type: DEVICE
Intervention: Panoramic Bracelet and GENEActiv
Description: Panoramic Bracelet:~The Panoramic Digital Health Bracelet is a wearable inertial measurement unit intended for use by researchers and healthcare professionals for high frequency or continuous collection of physical data in home and professional healthcare settings during research studies. It includes a 3 axis accelerometer and gyroscope, as well as magnetometer, pressure, and temperature sensors. The bracelet has no interface or screen for participants to interact with.~GENEActiv:~The GENEActiv device is a wearable inertial measurement unit designed for public health research and clinical trials. The device is a circular unit with attachable wrist-bands, and has no interface or screen for participants to interact with. The GENEActiv device is FDA 510(k) exempt. The device records acceleration data and can collect data remotely for up to 1 month.
Study NCT05003258 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Intravitreal injection of Dexamethasone implant
Description: Intravitreal injection of Dexamethasone implant
Study NCT05417594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD9574
Description: Participants will receive AZD9574 orally.
Study NCT05313399 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bonded spur
Description: Spur appliances change tongue action, close the open bite, and boost treatment stability, as it induces a permanent modification of the tongue's anterior rest posture by altering orofacial function, resulting in a change in form. Finally, the spur adjusts the sensory input to the brain. This proprioceptive change leads to an altered motor response, resulting in a new normal tongue rest posture (change in function) that allows the incisors to erupt
Study NCT06473116 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isoprenaline Only Product
Description: Administration of intravenous isoprenaline of 600 mikrograms immediately after recognition of asystole in bystander-witnessed out-of-hospital cardiac arrest
Study NCT06473116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isoprenaline Only Product
Description: Administration of intravenous isoprenaline of 600 mikrograms immediately after recognition of asystole in bystander-witnessed out-of-hospital cardiac arrest
Study NCT04727528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium zirconium cyclosilicate
Description: Investigational medicinal product
Study NCT05417594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Participants will receive temozolomide orally.
Study NCT04727528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Plabeco comparator
Study NCT05645302 — intervention group
Intervention type: DRUG
Intervention: Lidocaine Cataplasms
Description: The main ingredient of this product is lidocaine, the cream surface is white or almost white, the cream is evenly spread on the back, and the cream surface is covered with film.
Study NCT06267820 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: analgesia
Study NCT06267820 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketorolac
Description: analgesia
Study NCT05417594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [11C]AZ1419 3391
Description: Participants will receive \[11C\]AZ1419 3391 intravenously.
Study NCT05417594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab Deruxtecan (Dato-DXd)
Description: Participants will receive Dato-DXd intravenously.
Study NCT05417594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab Deruxtecan (T-DXd)
Description: Participants will receive T-DXd intravenously.
Study NCT06426277 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brazilian Diabetes Prevention Program (face-to-face care)
Description: A Program structured in 28 visits (in group and individual) and 21 contacts (through phone calls or video calls) to guide the improvement of diet quality, self-care, and regular practice of physical activity
Study NCT06426277 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diet
Description: Hypocaloric diet prescription
Study NCT06426277 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brazilian Diabetes Prevention Program (remote care)
Description: A Program structured in 49 contacts delivered through telehealth (through phone calls or video calls between professional and participant) to guide the improvement of diet quality, self-care, and regular practice of physical activity
Study NCT05701280 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation
Description: Deep Brain Stimulation (DBS) of the dentate nucleus area of the cerebellum plus motor rehabilitation to improve upper-extremity function.
Study NCT05701280 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation
Description: Motor rehabilitation to improve upper-extremity function.
Study NCT05205499 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
Description: Subjects in this arm will be treated with IBS
Study NCT06144112 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: fresh frozen plasma
Description: transfusion of fresh frozen plasma
Study NCT06144112 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: prothrombin complex concentrate
Description: prothrombin complex concentrate administration
Study NCT05927077 — intervention group
Intervention type: PROCEDURE
Intervention: planned surgery for weight reduction
Description: planned surgeries will be used to collect study material to determine chemical patterns in the study participants from the different geographical regions
Study NCT06082310 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Two HIIT modalities
Study NCT05114187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education Intervention
Description: Participants in the intervention group will be provided e-learning about dementia and promoting brain health, consisting of the following components:~1. Ten selected multimedia e-learning lessons;~2. A series of 16 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lessons.~Participants will have 8-weeks to complete the intervention. The total time to complete is approximately 5-6 hours.
Study NCT05114187 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education Control
Description: Participants in the control group will be provided e-learning about dementia and promoting brain health, consisting of the following components:~1. One selected multimedia e-learning lesson;~2. A series of 16 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lessons.~Participants will have 8-weeks to complete. The total time to complete is approximately 1-2 hours.~Note: All participants will receive access to all e-learning at the conclusion of the study.
Study NCT05136235 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Echocardiography
Description: There will be screened for pulmonary hypertension by means of serial echocardiographies during the study period
Study NCT05136235 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: NT-proBNP
Description: At 36 weeks postmenstrual age there will be screened for pulmonary hypertension by means of an NT-proBNP measurement in a blood sample
Study NCT05619315 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Charcoal -based whitening toothpaste
Description: The labial surface of anterior teeth will be brushed by the circular brushing technique twice daily (morning and after 6 hours) for at least 1 minute using charcoal containing toothpaste. Soft bristles toothbrushes will provided to all patients. After 1 month, re-evaluation of the stains will be performed and the data will be recorded.
Study NCT05619315 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Calcium carbonate /perlite containing whitening toothpaste.
Description: The labial surface of anterior teeth will be brushed by the circular brushing technique twice daily (morning and after 6hours) for at least 1 minute using (calcium carbonate /perlite) containing toothpaste. Soft bristles toothbrushes will provided to all patients. After 1 month, re-evaluation of the stains will be performed and the data will be recorded.
Study NCT05272553 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy
Description: NET (Schauer et al., 2011) is an evidence-based, short-term, manualised treatment for trauma-spectrum disorders; it aims to reduce symptoms of traumatic stress in individuals who continue to suffer from past experiences of traumatic stressors; NET combines principles of CBT, Testimony Therapy, and Exposure Therapy.
Study NCT05795491 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Azole Antifungal
Description: Azole antifungals are a group of medicines that contain an azole ring and inhibit the growth of a wide range of fungi
Study NCT05936021 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Algorithm model-based Aranesp doses
Description: Patients will receive doses calculated by the algorithm instead of by the standard of care procedures. Model-based Aranesp doses will be computed at the same time that doses based on the dialysis anemia protocol are determined. The model-based doses will be administered instead of the protocol-based doses and in the same way and at the same time as the protocol-based doses would have been. The model-based dosing will be more flexible than the protocol-based dosing. Some constraints in the protocol-based dosing were created to prevent patients from achieving high Hb levels. The model-based dosing will also prevent these high Hb values but will do so by predicting a patient's Hb level into the future and then using these predictions to determine doses to reduce Hb variability and to reduce the amount of Aranesp used.
Study NCT05936021 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Standard of care
Description: Current standard of care guidelines are followed for erythropoiesis-stimulating agents to control anemia in dialysis patients
Study NCT05355909 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Individualized high intensity preoperative fitness training
Description: The individualised training program consists of stamina training, interval training and strength training. The personalised fitness training will be designed based on the FITT-VP (frequency, intensity, time, type, volume, progression) of the American College of Sports Medicine (ACSM) and will contain 6 training session within 2 weeks under supervision of professional sport physicians.
Study NCT05686447 — intervention group
Intervention type: OTHER
Intervention: Observational studies, no intervention
Description: Observational studies, no intervention
Study NCT05002166 — intervention group
Intervention type: OTHER
Intervention: labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.
Description: labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.
Study NCT05667857 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrative neurocognitive remediation therapy
Description: Integrative Neurocognitive Remediation Therapy is a clinical program of 12 weeks (1 day/week) that combines personalized computerized cognitive training and neurocognitive strategy training, with group sessions of adapted physiotherapy, acceptance and commitment therapy (ACT), cognitive behavioral therapy (CBT) and information sessions on cognition, fatigue, nutrition and physical exercise.
Study NCT04849845 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Afrezza Dose 1
Description: The first dose of Afrezza will be based on the dose of subcutaneous rapid-acting analogue (RAA) insulin that the subject would normally take for the standardized meal, converted according to the guidelines provided in the current Afrezza U.S. prescribing information.
Study NCT04849845 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Afrezza Dose 2
Description: The second dose of Afrezza will be based on the dose of subcutaneous rapid-acting analogue that the subject would normally take for the standardized meal, converted by multiplying their RAA dose by 2 and rounding down to the nearest Afrezza cartridge size.
Study NCT05503004 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prehabilitation
Description: 10 min exercise, 5 min respiratory mindfulness, and preoperative nutrition assessment.
Study NCT05503004 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Standard care before surgery
Study NCT06214377 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Active Transcranial Direct Current Stimulation
Description: The Starstim tCS® equipment will be used, with 35 cm2 sponge electrodes. The tDCS over M1 will be performed by placing the active anode on the C3 point (10/20 EEG system) and the cathode on the contralateral supraorbital area (Fp2). Regarding the stimulated hemisphere, in cases of asymmetric pain, it will be applied to the contralateral M1, and in cases of bilateral pain, it will be applied to the M1 of the dominant hemisphere. A constant current of 2 mA (subthreshold intensity) will be applied for 20 minutes, with the first 30 seconds used as a ramp-up and the last 30 seconds as a ramp-down. Number of sessions: 1.
Study NCT06214377 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active Transcranial Direct Current Stimulation
Description: The Starstim tCS® equipment will be used, with 35 cm2 sponge electrodes. The tDCS over M1 will be performed by placing the active anode on the C3 point (10/20 EEG system) and the cathode on the contralateral supraorbital area (Fp2). Regarding the stimulated hemisphere, in cases of asymmetric pain, it will be applied to the contralateral M1, and in cases of bilateral pain, it will be applied to the M1 of the dominant hemisphere. A constant current of 2 mA (subthreshold intensity) will be applied for 20 minutes, with the first 30 seconds used as a ramp-up and the last 30 seconds as a ramp-down. Number of sessions: 1.